Graig Suvannavejh
Stock Analyst at Mizuho
(3.62)
# 848
Out of 4,996 analysts
164
Total ratings
48.78%
Success rate
6.87%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Graig Suvannavejh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HRMY Harmony Biosciences Holdings | Maintains: Outperform | $50 → $35 | $27.51 | +27.23% | 19 | Sep 25, 2025 | |
| IDYA IDEAYA Biosciences | Maintains: Outperform | $43 → $44 | $26.83 | +64.00% | 2 | Sep 12, 2025 | |
| BTAI BioXcel Therapeutics | Maintains: Neutral | $2 → $4 | $2.70 | +48.15% | 9 | Sep 12, 2025 | |
| KALA KALA BIO | Initiates: Outperform | $30 | $19.05 | +57.48% | 1 | Sep 8, 2025 | |
| INSM Insmed | Maintains: Outperform | $130 → $165 | $137.03 | +20.41% | 11 | Aug 13, 2025 | |
| APLS Apellis Pharmaceuticals | Maintains: Neutral | $21 → $22 | $22.39 | -1.74% | 10 | Aug 4, 2025 | |
| ALEC Alector | Upgrades: Outperform | $2.5 → $3.5 | $3.10 | +12.90% | 5 | Jul 28, 2025 | |
| NMRA Neumora Therapeutics | Maintains: Outperform | $4 → $5 | $1.74 | +187.36% | 2 | Jul 16, 2025 | |
| ADVM Adverum Biotechnologies | Maintains: Outperform | $16 → $12 | $4.51 | +166.08% | 5 | Jun 26, 2025 | |
| ADAP Adaptimmune Therapeutics | Downgrades: Neutral | $1.5 → $0.5 | $0.15 | +240.14% | 3 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $10 | $8.08 | +23.76% | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $11 | $7.39 | +48.85% | 3 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $30 → $26 | $13.90 | +87.05% | 5 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $7 → $8 | $14.52 | -44.90% | 7 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $33 | $34.02 | -3.00% | 8 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $212 → $216 | $116.76 | +84.99% | 21 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $7 → $7.6 | $1.56 | +387.18% | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $74 | $12.11 | +511.07% | 1 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $50 → $5 | $3.86 | +29.53% | 3 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $44 → $49 | $73.75 | -33.56% | 6 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $7.70 | +107.79% | 3 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $10 | $7.64 | +30.89% | 5 | Nov 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $17 → $1 | $5.26 | -80.99% | 5 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $35 | $99.16 | -64.70% | 5 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $8 | $15.80 | -49.37% | 6 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $71 → $57 | $50.40 | +13.10% | 2 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $8 → $5 | $35.50 | -85.92% | 4 | Apr 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $34 | $9.71 | +250.15% | 1 | Jun 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $28 | $6.56 | +326.83% | 1 | Apr 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $31 | $16.05 | +93.15% | 1 | Apr 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $380 | $33.62 | +1,030.28% | 1 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $4.75 | $1.78 | +166.85% | 1 | Nov 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $36 | $17.57 | +104.89% | 2 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $33.78 | - | 1 | Oct 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $37 | $1.50 | +2,366.67% | 1 | Oct 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $128 | $127.00 | +0.79% | 1 | Sep 14, 2020 |
Harmony Biosciences Holdings
Sep 25, 2025
Maintains: Outperform
Price Target: $50 → $35
Current: $27.51
Upside: +27.23%
IDEAYA Biosciences
Sep 12, 2025
Maintains: Outperform
Price Target: $43 → $44
Current: $26.83
Upside: +64.00%
BioXcel Therapeutics
Sep 12, 2025
Maintains: Neutral
Price Target: $2 → $4
Current: $2.70
Upside: +48.15%
KALA BIO
Sep 8, 2025
Initiates: Outperform
Price Target: $30
Current: $19.05
Upside: +57.48%
Insmed
Aug 13, 2025
Maintains: Outperform
Price Target: $130 → $165
Current: $137.03
Upside: +20.41%
Apellis Pharmaceuticals
Aug 4, 2025
Maintains: Neutral
Price Target: $21 → $22
Current: $22.39
Upside: -1.74%
Alector
Jul 28, 2025
Upgrades: Outperform
Price Target: $2.5 → $3.5
Current: $3.10
Upside: +12.90%
Neumora Therapeutics
Jul 16, 2025
Maintains: Outperform
Price Target: $4 → $5
Current: $1.74
Upside: +187.36%
Adverum Biotechnologies
Jun 26, 2025
Maintains: Outperform
Price Target: $16 → $12
Current: $4.51
Upside: +166.08%
Adaptimmune Therapeutics
Jun 26, 2025
Downgrades: Neutral
Price Target: $1.5 → $0.5
Current: $0.15
Upside: +240.14%
Jun 18, 2025
Maintains: Outperform
Price Target: $8 → $10
Current: $8.08
Upside: +23.76%
May 20, 2025
Maintains: Outperform
Price Target: $12 → $11
Current: $7.39
Upside: +48.85%
May 16, 2025
Maintains: Outperform
Price Target: $30 → $26
Current: $13.90
Upside: +87.05%
May 14, 2025
Maintains: Outperform
Price Target: $7 → $8
Current: $14.52
Upside: -44.90%
Apr 7, 2025
Maintains: Neutral
Price Target: $38 → $33
Current: $34.02
Upside: -3.00%
Mar 27, 2025
Maintains: Outperform
Price Target: $212 → $216
Current: $116.76
Upside: +84.99%
Nov 18, 2024
Upgrades: Buy
Price Target: $7 → $7.6
Current: $1.56
Upside: +387.18%
Sep 20, 2024
Reiterates: Outperform
Price Target: $74
Current: $12.11
Upside: +511.07%
Sep 19, 2024
Downgrades: Neutral
Price Target: $50 → $5
Current: $3.86
Upside: +29.53%
Jul 22, 2024
Maintains: Neutral
Price Target: $44 → $49
Current: $73.75
Upside: -33.56%
May 16, 2024
Maintains: Buy
Price Target: $14 → $16
Current: $7.70
Upside: +107.79%
Nov 27, 2023
Maintains: Buy
Price Target: $17 → $10
Current: $7.64
Upside: +30.89%
Jun 5, 2023
Downgrades: Neutral
Price Target: $17 → $1
Current: $5.26
Upside: -80.99%
Nov 10, 2022
Maintains: Buy
Price Target: $31 → $35
Current: $99.16
Upside: -64.70%
Nov 10, 2022
Maintains: Neutral
Price Target: $9 → $8
Current: $15.80
Upside: -49.37%
May 24, 2022
Maintains: Buy
Price Target: $71 → $57
Current: $50.40
Upside: +13.10%
Apr 19, 2022
Maintains: Sell
Price Target: $8 → $5
Current: $35.50
Upside: -85.92%
Jun 1, 2021
Initiates: Buy
Price Target: $34
Current: $9.71
Upside: +250.15%
Apr 20, 2021
Initiates: Neutral
Price Target: $28
Current: $6.56
Upside: +326.83%
Apr 19, 2021
Initiates: Neutral
Price Target: $31
Current: $16.05
Upside: +93.15%
Mar 2, 2021
Initiates: Sell
Price Target: $380
Current: $33.62
Upside: +1,030.28%
Nov 24, 2020
Initiates: Neutral
Price Target: $4.75
Current: $1.78
Upside: +166.85%
Nov 9, 2020
Upgrades: Buy
Price Target: $36
Current: $17.57
Upside: +104.89%
Oct 21, 2020
Downgrades: Sell
Price Target: n/a
Current: $33.78
Upside: -
Oct 20, 2020
Initiates: Neutral
Price Target: $37
Current: $1.50
Upside: +2,366.67%
Sep 14, 2020
Downgrades: Sell
Price Target: $128
Current: $127.00
Upside: +0.79%